Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
15-Dec-2022Recurrent Prostate Cancer Diagnostics with 18F-PSMA-1007 PET/CT: A Systematic Review of the Current StateSaule, Laura; Radzina, Maija; Liepa, Mara; Roznere, Lilita; Lioznovs, Andrejs; Ratniece, Madara; Mamis, Edgars; Vjaters, Egils; Department of Radiology
Mar-2023A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastasesThellenberg-Karlsson, Camilla; Vjaters, Egils; Kase, Marju; Tammela, Teuvo; Ojamaa, Kristiina; Norming, Ulf; Nyman, Claes; Andersson, Sven Olof; Hublarovs, Oleg; Marquez-Holmberg, Marcela; Castellanos, Enrique; Ullen, Anders; Holmberg, Anders; Nilsson, Sten
1-May-2016Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer : An Open-label Phase 1 StudyMassard, Christophe; Penttinen, Heidi M.; Vjaters, Egils; Bono, Petri; Lietuvietis, Vilnis; Tammela, Teuvo L.; Vuorela, Annamari; Nykänen, Pirjo; Pohjanjousi, Pasi; Snapir, Amir; Fizazi, Karim
15-Oct-2021Diagnostic scope of 18 F-PSMA-1007 PET/CT : comparison with multiparametric MRI and bone scintigraphy for the assessment of early prostate cancer recurrenceSaule, Laura; Radzina, Maija; Liepa, Māra; Roznere, Lilita; Kalnina, Marika; Lioznovs, Andrejs; Mamis, Edgars; Mikelsone, Madara; Biederer, Juergen; Vjaters, Egils; Department of Radiology; Rīga Stradiņš University; Statistics Unit; RSU Institute of Oncology
1-Sep-2021Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer : An analysis of the phase III ARAMIS trialSmith, Matthew R.; Shore, Neal; Tammela, Teuvo L.; Ulys, Albertas; Vjaters, Egils; Polyakov, Sergey; Jievaltas, Mindaugas; Luz, Murilo; Alekseev, Boris; Kuss, Iris; Le Berre, Marie Aude; Mohamed, Ateesha F.; Odom, Dawn; Bartsch, Jennifer; Snapir, Amir; Sarapohja, Toni; Fizazi, Karim
15-Feb-2008Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors : Results of a phase I studyAlbertella, Mark R.; Loadman, Paul M.; Jones, Philip H.; Phillips, Roger M.; Rampling, Roy; Burnet, Neil; Alcock, Chris; Anthoney, Alan; Vjaters, Egils; Dunk, Chris R.; Harris, Peter A.; Wong, Alvin; Lalani, Alshad S.; Twelves, Chris J.
2020Accuracy of 68Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancerRadzina, Maija; Tirane, Mara; Roznere, Lilita; Zemniece, Liene; Dronka, Laura; Kalnina, Marika; Mamis, Edgars; Biederer, Juergen; Lietuvietis, Vilnis; Freimanis, Arvis; Vjaters, Egils; Department of Radiology
2011Epidemiologic, clinical, and molecular characteristics of hereditary prostate cancer in LatviaAbele, Andris; Vjaters, Egils; Irmejs, Arvids; Trofimovičs, Genadijs; Miklaševičs, Edvins; Gardovskis, Janis; RSU Institute of Oncology
Oct-2023Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trialFizazi, Karim; Shore, Neal D; Smith, Matthew; Ramos, Rodrigo; Jones, Robert; Niegisch, Günter; Vjaters, Egils; Wang, Yuan; Srinivasan, Shankar; Sarapohja, Toni; Verholen, Frank